Ionis poised for continued momentum in 2024 with product launches and key advances in robust pipeline of investigational medicines for serious diseases

January 8, 2024

https://www.prnewswire.com/news-releases/ionis-poised-for-continued-momentum-in-2024-with-product-launches-and-key-advances-in-robust-pipeline-of-investigational-medicines-for-serious-diseases-302028429.html

– Numerous value-driving commercial, regulatory and pipeline milestones anticipated –

CARLSBAD, Calif., Jan. 8, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced highlights from the Company’s 2023 achievements and previewed a number of important milestones expected in 2024. Ionis will provide a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 3pm PT; the presentation is available today on the Ionis website.

Read more at prnewswire.com

Related news for (IONS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.